These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Antiphospholipid syndrome; its implication in cardiovascular diseases: a review. Koniari I; Siminelakis SN; Baikoussis NG; Papadopoulos G; Goudevenos J; Apostolakis E J Cardiothorac Surg; 2010 Nov; 5():101. PubMed ID: 21047408 [TBL] [Abstract][Full Text] [Related]
31. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Alijotas-Reig J; Vilardell-Tarres M Obstet Gynecol Surv; 2010 Jan; 65(1):39-45. PubMed ID: 20040128 [TBL] [Abstract][Full Text] [Related]
32. Antiphospohlipid syndrome in obstetrics. Danza A; Ruiz-Irastorza G; Khamashta M Best Pract Res Clin Obstet Gynaecol; 2012 Feb; 26(1):65-76. PubMed ID: 22079775 [TBL] [Abstract][Full Text] [Related]
33. Tomography and blood vessels in Hughes syndrome. Stojanovich L; Djokovic A Lupus; 2014 Apr; 23(4):337-41. PubMed ID: 24436444 [TBL] [Abstract][Full Text] [Related]
34. Clinical consequences of antiphospholipid antibodies. Derksen RH; de Groot PG Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067 [TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibody syndrome: a case report and review of the literature. Weaver CA S D J Med; 1991 Oct; 44(10):285-8. PubMed ID: 1801188 [TBL] [Abstract][Full Text] [Related]
36. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. Fishman P; Falach-Vaknine E; Zigelman R; Bakimer R; Sredni B; Djaldetti M; Shoenfeld Y J Clin Invest; 1993 Apr; 91(4):1834-7. PubMed ID: 8473523 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention. Tufano A; Guida A; Di Minno MN; De Gregorio AM; Cerbone AM; Di Minno G Nutr Metab Cardiovasc Dis; 2010 May; 20(4):217-23. PubMed ID: 20153613 [TBL] [Abstract][Full Text] [Related]
38. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity. Xie H; Sheng L; Zhou H; Yan J Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619 [TBL] [Abstract][Full Text] [Related]
39. Organ specific complement proteins inhibition can reduce the risk of antiphospholipid antibodies mediated fetal loss. Amarnath A; Archunan G Med Hypotheses; 2013 Jan; 80(1):65-6. PubMed ID: 23151526 [TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid syndrome. Current insights into laboratory diagnosis and pathophysiology. van Os GM; Urbanus RT; Agar C; Meijers JC; de Groot PG Hamostaseologie; 2010 Aug; 30(3):139-43. PubMed ID: 20680233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]